Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)
HKD 57.35
(4.08%)
HKD 57.35
(4.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 147.24 Million CNY | 6.44% |
| 2022 | 138.34 Million CNY | -68.16% |
| 2021 | 434.48 Million CNY | 4152.31% |
| 2020 | 10.21 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 186 Million CNY | 132.5% |
| 2015 | 80 Million CNY | 14.42% |
| 2014 | 69.92 Million CNY | 12.77% |
| 2013 | 62 Million CNY | -1.59% |
| 2012 | 63 Million CNY | -8.7% |
| 2011 | 69 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 143.57 Million CNY | -2.5% |
| 2024 Q2 | 164.89 Million CNY | 14.85% |
| 2024 Q3 | - CNY | -48.36% |
| 2023 Q4 | 147.24 Million CNY | 16.22% |
| 2023 Q2 | 133.79 Million CNY | -0.64% |
| 2023 FY | 147.24 Million CNY | 6.44% |
| 2023 Q3 | 126.7 Million CNY | -5.3% |
| 2023 Q1 | 134.65 Million CNY | -2.67% |
| 2022 Q3 | 59.4 Million CNY | -7.56% |
| 2022 FY | 138.34 Million CNY | -68.16% |
| 2022 Q4 | 138.34 Million CNY | 132.9% |
| 2022 Q2 | 64.26 Million CNY | -85.34% |
| 2022 Q1 | 438.43 Million CNY | 0.91% |
| 2021 Q1 | 5.25 Million CNY | -48.59% |
| 2021 Q2 | 46.34 Million CNY | 782.34% |
| 2021 Q4 | 434.48 Million CNY | 955.35% |
| 2021 FY | 434.48 Million CNY | 4152.31% |
| 2021 Q3 | 41.16 Million CNY | -11.17% |
| 2020 Q3 | 150 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 10.21 Million CNY | -93.19% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 FY | 10.21 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q3 | 30 Million CNY | 0.0% |
| 2019 Q4 | - CNY | -100.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q3 | 86 Million CNY | -25.86% |
| 2016 Q4 | 186 Million CNY | 116.28% |
| 2016 Q2 | 116 Million CNY | 0.0% |
| 2016 FY | 186 Million CNY | 132.5% |
| 2015 FY | 80 Million CNY | 14.42% |
| 2015 Q4 | 80 Million CNY | 0.0% |
| 2014 FY | 69.92 Million CNY | 12.77% |
| 2013 FY | 62 Million CNY | -1.59% |
| 2012 FY | 63 Million CNY | -8.7% |
| 2011 FY | 69 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -178.527% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 97.517% |